Ultiva

Product manufactured by Mylan Institutional Llc

Application Nr Approved Date Route Status External Links
NDA020630 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Ultiva Is Indicated For Intravenous (Iv) Administration: • As An Analgesic Agent For Use During The Induction And Maintenance Of General Anesthesia For Inpatient And Outpatient Procedures. • For Continuation As An Analgesic Into The Immediate Postoperative Period In Adult Patients Under The Direct Supervision Of An Anesthesia Practitioner In A Postoperative Anesthesia Care Unit Or Intensive Care Setting. • As An Analgesic Component Of Monitored Anesthesia Care In Adult Patients. Ultiva Is An Opioid Agonist Indicated For Intravenous Administration: • As An Analgesic Agent For Use During The Induction And Maintenance Of General Anesthesia For Inpatient And Outpatient Procedures. ( 1 ) • For Continuation As An Analgesic Into The Immediate Postoperative Period In Adult Patients Under The Direct Supervision Of An Anesthesia Practitioner In A Postoperative Anesthesia Care Unit Or Intensive Care Setting. ( 1 ) • As An Analgesic Component Of Monitored Anesthesia Care In Adult Patients. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Remifentanil Hydrochloride REMIFENTANIL HYDROCHLORIDE ZINC538283

Comments